Literature DB >> 26179668

Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum.

Kongsak Loharamtaweethong1, Napaporn Puripat1, Nadda Aoonjai2, Apisada Sutepvarnon3, Chanyoot Bandidwattanawong3.   

Abstract

AIMS: To report a case of paediatric malignant peritoneal mesothelioma (MPM) with evidence of anaplastic lymphoma kinase (ALK) translocation. METHODS AND
RESULTS: We describe a 10-year-old girl who presented with abdominal pain and progressive abdominal distension. She had no history of asbestos exposure. Histopathological, immunohistochemical and ultrastructural analyses were performed and showed a biphasic malignant mesothelioma. In addition, we also studied on a selected set of immunomarkers which may be the potential therapeutic molecular targets including ALK, c-kit (CD117), epidermal growth factor receptor (EGFR) and human epidermal growth factor 2 (HER2)/neu, as well as corresponding molecular analysis. Consequently, we identified ALK expression by immunohistochemistry, together with evidence of ALK translocation by fluorescent in-situ hybridization (FISH) analysis.
CONCLUSIONS: Paediatric MPM is associated with ALK translocation in our case. The results may open up a new avenue for the study of molecular genesis of paediatric malignant mesothelioma in the future and help to determine whether patients MMs with ALK translocation would benefit from ALK inhibitor treatment.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  anaplastic lymphoma kinase; child; malignant peritoneal mesothelioma

Mesh:

Substances:

Year:  2015        PMID: 26179668     DOI: 10.1111/his.12779

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  11 in total

1.  A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions.

Authors:  Patrice Desmeules; Philippe Joubert; Lei Zhang; Hikmat A Al-Ahmadie; Christopher D Fletcher; Efsevia Vakiani; Deborah F Delair; Natasha Rekhtman; Marc Ladanyi; William D Travis; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2017-07       Impact factor: 6.394

2.  Novel insights and recent discoveries on the genetics and pathogenesis of malignant mesothelioma.

Authors:  Yin P Hung; Lucian R Chirieac
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

3.  Molecular characterization of diffuse malignant peritoneal mesothelioma.

Authors:  Yin P Hung; Fei Dong; Matthew Torre; Christopher P Crum; Raphael Bueno; Lucian R Chirieac
Journal:  Mod Pathol       Date:  2020-06-05       Impact factor: 7.842

Review 4.  A Novel Malignant Peritoneal Mesothelioma with STRN Exon 2 and ALK Exon 20: A Case Report and Literature Review.

Authors:  Chiho Miyagawa; Hisamitsu Takaya; Kazuko Sakai; Kazuto Nishio; Maho Konishi; Sachiko Minamiguchi; Toshihide Shimada; Noriomi Matsumura
Journal:  Oncologist       Date:  2021-02-22

Review 5.  The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma.

Authors:  Nirosha D Perera; Aaron S Mansfield
Journal:  Curr Oncol Rep       Date:  2022-06-03       Impact factor: 5.075

Review 6.  New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.

Authors:  Anne S Tsao; Harvey I Pass; Andreas Rimner; Aaron S Mansfield
Journal:  J Clin Oncol       Date:  2022-01-05       Impact factor: 44.544

7.  Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma.

Authors:  Idrees Mian; Zied Abdullaev; Betsy Morrow; Rosandra N Kaplan; Shaojian Gao; Markku Miettinen; David S Schrump; Valerie Zgonc; Jun S Wei; Javed Khan; Svetlana Pack; Raffit Hassan
Journal:  J Thorac Oncol       Date:  2019-11-26       Impact factor: 15.609

8.  Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 Cases.

Authors:  Pedram Argani; Derrick W Q Lian; Abbas Agaimy; Markus Metzler; Sara E Wobker; Andres Matoso; Jonathan I Epstein; Yun-Shao Sung; Lei Zhang; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2021-05-01       Impact factor: 6.298

9.  ALK alterations in salivary gland carcinomas.

Authors:  Hanna Majewska; Adam Gorczyński; Piotr Czapiewski; Roopika Menon; Judith Mueller; Sotirios Lakis; Johannes M Heuckmann; Jan Laco; Ruta Gupta; Simon Andreasen; Dominik Stodulski; Mariola Iliszko; Rafał Dziadziuszko; Jacek Jassem; Lukas C Heukamp; Wojciech Biernat
Journal:  Virchows Arch       Date:  2020-11-25       Impact factor: 4.064

10.  Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.

Authors:  Yin P Hung; Fei Dong; Jaclyn C Watkins; Valentina Nardi; Raphael Bueno; Paola Dal Cin; John J Godleski; Christopher P Crum; Lucian R Chirieac
Journal:  JAMA Oncol       Date:  2018-02-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.